Mead infant formula recall
This article was originally published in The Tan Sheet
BMS subsidiary initiates voluntary recall of 505 cases of EnfaCare LIPIL 12.9 oz. powdered formula due to contamination with Enterobacter sakazakii bacteria, FDA announces Jan. 9. Cases and cans are coded BME01, with an expiration date of Jan. 1, 2004, and were shipped to hospitals, retail stores and Women, Infant & Children clinics nationwide, firm says. Mead Johnson notes it has not received adverse event reports associated with the batch; E. sakazakii has been linked to rare cases of sepsis, meningitis, necrotizing enterocolitis in newborn infants. Bacteria has posed problems for several powdered infant formula manufacturers in the past; both Mead and Wyeth recalled formula in 2002...
You may also be interested in...
The "many changes in the formulation and marketing practices of infant formula in recent years" will be the subject of two upcoming "listening sessions" sponsored by the California Special Supplemental Nutrition Program for Women, Infants & Children
Legal experts explain why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.
Ex-Novartis executive and co-founder of investment bank MM Dillon & Co shares insights around where healthcare unicorns can be found and some core criteria to build such firms.